Michael Conick Hanley Jr.
Chief Commercial Officer, Aeglea BioTherapeutics.
Companies
- Alto Neuroscience, Inc.Chief operating officer May 22, 2024 to now1
- Aeglea BioTherapeuticsChief Commercial Officer Oct 23, 2019 to Feb 24, 20232
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Aeglea BioTherapeutics SYRE36,200 shares3$3.1M at $85.57Jun 8, 2022
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 8, 2022Bought 28,200 shares at $0.71 of Aeglea BioTherapeutics3
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3